Challenges and perspectives of tobacco cessation in special groups of patients and populations.


Journal

Breathe (Sheffield, England)
ISSN: 1810-6838
Titre abrégé: Breathe (Sheff)
Pays: England
ID NLM: 101231007

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 18 01 2023
accepted: 27 06 2023
medline: 30 8 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

During the first 2 years of the coronavirus disease 2019 pandemic, health systems worldwide were put under extreme pressure, and healthcare professionals had to manage unprecedented health crises as well as provide healthcare services to an increased number of patients. Therefore, public health policies with respect to smoking and education of the general population regarding the harmful effects of active and second-hand smoking may not have received adequate attention during this period. More specifically, certain subpopulations suffering from chronic diseases may not have received adequate information about the effects of smoking on the course and outcome of their disease; high-level, evidence-based pharmaceutical therapies; and the potential for follow-up. However, adequate education and awareness regarding short- and long-term health benefits from smoking cessation for the general population as well as special subgroups remains of utmost importance. Healthcare professionals should understand that it is only through high-quality evidence and results from independent studies that they will be able to provide their expertise and scientific knowledge concerning newer tobacco products and their effects on human health.

Identifiants

pubmed: 37645019
doi: 10.1183/20734735.0224-2022
pii: EDU-0224-2022
pmc: PMC10461735
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

220224

Informations de copyright

Copyright ©ERS 2023.

Déclaration de conflit d'intérêts

Conflict of interest: All authors declare no conflict of interest.

Références

Lancet Respir Med. 2021 May;9(5):435
pubmed: 33844994
Lancet. 2016 Jun 18;387(10037):2507-20
pubmed: 27116918
Eur Respir J. 2013 Mar;41(3):716-26
pubmed: 22903959
JAMA. 2006 Jul 5;296(1):47-55
pubmed: 16820546
Int J Environ Res Public Health. 2022 Apr 20;19(9):
pubmed: 35564394
J Prev Med Public Health. 2018 Sep;51(5):257-262
pubmed: 30286598
Eur Respir J. 2005 Jun;25(6):1011-7
pubmed: 15929955
Chest. 2011 Mar;139(3):591-599
pubmed: 20864613
Tob Control. 2022 Mar;31(2):250-256
pubmed: 35241597
Nicotine Tob Res. 2005 Feb;7(1):139-48
pubmed: 15804686
Lancet Oncol. 2021 Sep;22(9):1217
pubmed: 34364410
Braz J Psychiatry. 2021 Feb 01;43(1):75-82
pubmed: 32491035
Chest. 2006 Aug;130(2):334-42
pubmed: 16899830
Lancet. 2001 May 19;357(9268):1571-5
pubmed: 11377644
Sci Rep. 2019 Nov 27;9(1):17699
pubmed: 31776400
Arch Intern Med. 2005 Oct 24;165(19):2286-92
pubmed: 16246996
Front Pharmacol. 2019 Sep 09;10:981
pubmed: 31551784
Pediatr Clin North Am. 2019 Dec;66(6):1053-1062
pubmed: 31679596
Chest. 2016 Jul;150(1):164-79
pubmed: 27102185
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Am J Respir Crit Care Med. 2006 Jul 15;174(2):127-33
pubmed: 16645173
Cochrane Database Syst Rev. 2016 May 09;(5):CD006103
pubmed: 27158893
Addiction. 2022 Feb;117(2):299-311
pubmed: 34159677
Int J Chron Obstruct Pulmon Dis. 2018 May 29;13:1775-1781
pubmed: 29881267
Oncology (Williston Park). 2014 Mar;28(3):180, 182-3, 210
pubmed: 24855724
Int J Environ Res Public Health. 2018 May 21;15(5):
pubmed: 29883409
J Allergy Clin Immunol. 2012 Nov;130(5):1221-4
pubmed: 22608574
PLoS One. 2019 Aug 28;14(8):e0221783
pubmed: 31461485
Ann Allergy Asthma Immunol. 2016 Dec;117(6):641-645
pubmed: 27979021
Tob Control. 2022 Mar;31(2):175-182
pubmed: 35241585
Cochrane Database Syst Rev. 2018 May 31;5:CD000146
pubmed: 29852054
Chest. 2001 May;119(5):1365-70
pubmed: 11348940
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90
pubmed: 10673175
Int J Environ Res Public Health. 2020 Apr 10;17(7):
pubmed: 32290288
Annu Rev Public Health. 2016;37:149-66
pubmed: 26772406
Eur Respir J. 2009 Sep;34(3):634-40
pubmed: 19357145
J Asthma Allergy. 2016 Jun 24;9:117-28
pubmed: 27445499
Health Psychol. 1994 Jul;13(4):354-61
pubmed: 7957014
Cochrane Database Syst Rev. 2020 Apr 22;4:CD000031
pubmed: 32319681
Monaldi Arch Chest Dis. 2017 Dec 19;87(3):874
pubmed: 29424192
Chest. 2022 Feb;161(2):318-329
pubmed: 34699773
J Adolesc Health. 2015 Jul;57(1):46-51
pubmed: 26095408
Eur Respir J. 2021 Dec 31;59(1):
pubmed: 34667060
East Mediterr Health J. 2021 Jan 23;27(1):76-82
pubmed: 33538322
Respir Med. 2015 Nov;109(11):1416-22
pubmed: 26427627
Cochrane Database Syst Rev. 2016 Apr 10;4:CD006611
pubmed: 27060875
PLoS One. 2018 Aug 22;13(8):e0201881
pubmed: 30133533
Addict Behav. 2015 Jun;45:150-5
pubmed: 25678303
Cochrane Database Syst Rev. 2017 Nov 17;11:CD003289
pubmed: 29148565
Respir Med. 2014 Apr;108(4):577-83
pubmed: 24560410
BMJ Open. 2019 Jun 4;9(6):e023450
pubmed: 31167855
Thorax. 2017 Oct;72(10):905-911
pubmed: 28473506
Lancet. 2022 Jun 11;399(10342):2227-2242
pubmed: 35533707
J Pers Med. 2021 Sep 27;11(10):
pubmed: 34683102
Eur Respir J. 2007 Feb;29(2):390-417
pubmed: 17264326
Tob Prev Cessat. 2017 Mar 01;3:5
pubmed: 32432180
BMC Pulm Med. 2019 Oct 16;19(1):180
pubmed: 31619218
Front Public Health. 2021 Jul 05;9:664748
pubmed: 34291026
Tob Induc Dis. 2022 May 10;20:46
pubmed: 35611069
Curr Med Res Opin. 2007 Apr;23(4):793-801
pubmed: 17407636
Lancet Respir Med. 2022 May;10(5):497-511
pubmed: 35427530
JAMA. 2006 Jul 5;296(1):56-63
pubmed: 16820547
J Adolesc Health. 2021 Apr;68(4):649-657
pubmed: 33191057
Health Policy. 2019 May;123(5):480-491
pubmed: 30922630
Eur Respir J. 2013 Mar;41(3):727-34
pubmed: 22936706
Int J Environ Res Public Health. 2022 Oct 14;19(20):
pubmed: 36293800
Tob Control. 2007 Dec;16(6):e8
pubmed: 18048598
Eur Respir J. 2004 Nov;24(5):822-33
pubmed: 15516679
Eur Respir J. 2017 May 23;49(5):
pubmed: 28536250
J Adolesc Health. 2019 Feb;64(2):149-157
pubmed: 30447952
Clin Exp Allergy. 2014 Mar;44(3):353-61
pubmed: 24286379
Int J Tuberc Lung Dis. 2009 Feb;13(2):151-2
pubmed: 19146740
Diabetes Care. 2020 Jan;43(Suppl 1):S48-S65
pubmed: 31862748
Am J Psychiatry. 2014 Nov 1;171(11):1199-205
pubmed: 24934962
Cochrane Database Syst Rev. 2016 Aug 20;(8):CD010744
pubmed: 27545342
Contemp Clin Trials. 2014 Jul;38(2):304-13
pubmed: 24861558
Lancet. 2021 Jun 19;397(10292):2337-2360
pubmed: 34051883
Tob Control. 2023 May;32(3):402-404
pubmed: 34511407

Auteurs

Stamatoula Tsikrika (S)

Sotiria Thoracic Diseases Hospital of Athens, Athens, Greece.

Siyu Dai (S)

Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Asli Dilektasli (A)

Department of Pulmonary Medicine, Bursa Uludag University, Bursa, Turkey.

Paraskevi Katsaounou (P)

National and Kapodistrian University of Athens, 1st Department of Critical Care and Pulmonary Medicine, Evaggelismos Hospital, Athens, Greece.

Elif Dagli (E)

Marmara and Acibadem University, Istanbul, Turkey.

Classifications MeSH